Point72 Middle East FZE’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-21,764
Closed -$1.79M 814
2023
Q4
$1.79M Buy
+21,764
New +$1.66M 0.05% 421
2023
Q2
Sell
-172,601
Closed -$14.9M 1869
2023
Q1
$13.9M Buy
172,601
+148,343
+612% +$12.1M 0.47% 43
2022
Q4
$1.89M Buy
+24,258
New +$1.97M 0.08% 320

Other funds holding MDT

Point72 Middle East FZE's MDT Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Medtronic (MDT) in Q1 2024, closing a stake of 21,764 shares — an estimated $1.79M sold.

Point72 Middle East FZE first reported a position in MDT in Q4 2022 and held it in 3 quarters. The position peaked at $13.9M in Q1 2023. 2,075 funds tracked by Wall St. Rank hold MDT as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Medtronic position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 21,764 Medtronic shares in Q1 2024, an estimated $1.79M.
  • Point72 Middle East FZE first reported a position in Medtronic in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Medtronic position peaked at $13.9M in Q1 2023.
  • 2,075 funds tracked by Wall St. Rank held Medtronic as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.